Friday, June 25, 2021
10:51 AM EST – Antibe Therapeutics Inc. : Announced a strategic collaboration with Dalriada Drug Discovery to develop new drug candidates and fortify Antibe’s intellectual property position for its current pipeline. Antibe Therapeutics Inc. (T.ATE) shares were down $0.02 at 3.75.
Stocks in Play: Antibe Therapeutics Inc., Fri, 25 Jun 2021 10:57:08 EST